A Bibliometric Analysis on Research Trends in Paediatric Epilepsy Treatment From 2005 to 2025
Abstract The objective of this bibliometric analysis was to evaluate trends in paediatric epilepsy treatment research from 2005 to 2025.…
Anti-epileptic drugs
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population
Abstract In the landscape of paediatric epilepsy treatment, over 20 anti-seizure medications (ASMs) have gained approval from Drug Regulatory Agencies,…
The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study
Abstract Background: Approximately 30% of dogs with idiopathic epilepsy (IE) are drug‐resistant. Recent studies have suggested cannabidiol (CBD) may be…
Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy
Abstract Refractory epilepsy is a chronic brain network disorder characterized by unresponsiveness to multiple (>2) anti-epileptic drugs. Cannabidiol, a non-psychotropic…
Interpol review of controlled substances 2016–2019☆
Abstract This review paper covers the forensic-relevant literature in controlled substances from 2016 to 2019 as a part of the…